Publications

Detailed Information

Improved Outcome of Adult Recipients with a High Model for End-Stage Liver Disease Score and a Small-For-Size Graft

DC Field Value Language
dc.contributor.authorYi, Nam-Joon-
dc.contributor.authorSuh, Kyung-Suk-
dc.contributor.authorLee, Hae Won-
dc.contributor.authorShin, Woo Young-
dc.contributor.authorKim, Won-
dc.contributor.authorYoon, Jung-Hwan-
dc.contributor.authorLee, Kuhn Uk-
dc.contributor.authorLee, Hyo-Suk-
dc.contributor.authorKim, Yoon Jun-
dc.contributor.authorKim, Juhyun-
dc.date.accessioned2012-05-25T01:10:20Z-
dc.date.available2012-05-25T01:10:20Z-
dc.date.issued2009-05-
dc.identifier.citationLIVER TRANSPLANTATION; Vol.15 5; 496-503ko_KR
dc.identifier.issn1527-6465-
dc.identifier.urihttps://hdl.handle.net/10371/76448-
dc.description.abstractAlthough adult-to-adult living donor liver transplantation (ALDLT) has shown comparable outcomes to deceased donor liver transplantation, the outcome of patients with a high MELD score (>25) and a small-for-size graft (SFSG<0.8% of graft-to-recipient weight ratio) is not known. For 7 years, 167 consecutive hepatitis B virus-infected recipients underwent ALDLT at our institution. Based on their MELD score without additional score for hepatocellular carcinoma (HCC), the recipients were divided into Group L (low MELD score, n = 105) or Group H (high MELD score, n = 62). To analyze the risk of the graft size, the patients were further stratified as follows: Group Hs (high MELD score and SFSG, n = 11), Hn (high MELD score and normal size graft, In 51), Ls (low MELD score and SFSG, In 18), and Ln (low MELD score and normal size graft, n = 87). The primary endpoint was one-year patient survival rate (1-YSR). The mean follow-up period was 32.6 months. The mean MELD scores were 17.1 in Group L and 32.6 in Group H. Group H had more patients with the complications of cirrhosis but less patients with HCC than Group L (p < 0.05). However, major morbidity rates and 1-YSR were similar in comparisons between Group L (46.7% and 86.7%) and H (59.7% and 83.8%) (p > 0.05). 1-YSR was similar among Group Hs (72.7%), Hn (86.3%), Ls (83.3%), and Ln (88.5%) groups (p = 0.278). The multivariate analysis revealed accompanying HCC and the year of transplant were risk factors for poor 1-YSR. However, 1-YSR without HCC patients was also similar in comparisons between group L (90.2%) and H (91.7%) (p = 0.847), and among Group Hs (80.0%), Hn (94.7%), Ls (72.7%), and Ln (96.7%) (p = 0.072). In conclusion, high MELD score (>25) didn`t predict 1-YSR in ALDLT. Improvement of the 1-YSR might be affected by center`s experience as well as the selection of patients with low risk of recurrence of HCC. Liver Transpl 15:496-503, 2009. (C) 2009 AASLD.ko_KR
dc.language.isoenko_KR
dc.publisherJOHN WILEY & SONS INCko_KR
dc.titleImproved Outcome of Adult Recipients with a High Model for End-Stage Liver Disease Score and a Small-For-Size Graftko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor이남준-
dc.contributor.AlternativeAuthor서경석-
dc.contributor.AlternativeAuthor이해원-
dc.contributor.AlternativeAuthor신우영-
dc.contributor.AlternativeAuthor김주현-
dc.contributor.AlternativeAuthor김원-
dc.contributor.AlternativeAuthor김윤준-
dc.contributor.AlternativeAuthor윤정환-
dc.contributor.AlternativeAuthor이효석-
dc.contributor.AlternativeAuthor이건욱-
dc.identifier.doi10.1002/lt.21606-
dc.citation.journaltitleLIVER TRANSPLANTATION-
dc.description.citedreferenceYI NJ, 2008, WORLD J SURG, V14-
dc.description.citedreferenceYi NJ, 2007, LIVER TRANSPLANT, V13, P1159, DOI 10.1002/lt.21213-
dc.description.citedreferenceYi NJ, 2007, LIVER TRANSPLANT, V13, P797, DOI 10.1002/lt.21030-
dc.description.citedreferenceYang SH, 2007, SURGERY, V141, P598, DOI 10.1016/j.surg.2006.11.006-
dc.description.citedreferenceTerrault NA, 2007, LIVER TRANSPLANT, V13, P122, DOI 10.1002/lt.20995-
dc.description.citedreferenceChan SC, 2007, LIVER TRANSPLANT, V13, P91, DOI 10.1002/lt.20987-
dc.description.citedreferenceCHO EH, 2007, TRANSPL INT, V9, P779-
dc.description.citedreferenceYang SH, 2006, LIVER TRANSPLANT, V12, P1655, DOI 10.1002/lt.20861-
dc.description.citedreferenceUchida Y, 2006, AM J TRANSPLANT, V6, P2443, DOI 10.1111/j.1600-6143.2006.01487.x-
dc.description.citedreferenceCho JY, 2006, LIVER TRANSPLANT, V12, P1403, DOI 10.1002/lt.20772-
dc.description.citedreferenceXia VW, 2006, LIVER TRANSPLANT, V12, P614, DOI 10.1002/lt.20679-
dc.description.citedreferenceHabib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721-
dc.description.citedreferenceSuh KS, 2006, HEPATO-GASTROENTEROL, V53, P253-
dc.description.citedreferenceBruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933-
dc.description.citedreferenceOlthoff KM, 2005, ANN SURG, V242, P314, DOI 10.1097/01.sla.0000179646.37145.cf-
dc.description.citedreferenceBusuttil RW, 2005, ANN SURG, V241, P905, DOI 10.1097/01.sla.0000164077.77912.98-
dc.description.citedreferenceSantori G, 2005, TRANSPLANT INT, V18, P65, DOI 10.1111/j.1432-2277.2004.00024.x-
dc.description.citedreferenceBroering DC, 2004, ANN SURG, V240, P1002, DOI 10.1097/01.sla.0000146148.01586.72-
dc.description.citedreferenceThuluvath PJ, 2004, LIVER TRANSPLANT, V10, P1263, DOI 10.1002/lt.20254-
dc.description.citedreferenceDindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae-
dc.description.citedreferenceJacob M, 2004, LIVER TRANSPLANT, V10, P903, DOI 10.1002/lt.20169-
dc.description.citedreferenceDesai NM, 2004, TRANSPLANTATION, V77, P99, DOI 10.1097/01.TP.0000101009.91516.FC-
dc.description.citedreferenceSUH KS, 2004, CURR OPIN ORGAN TRAN, V9, P90-
dc.description.citedreferenceKiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198-
dc.description.citedreferenceHayashi PH, 2003, LIVER TRANSPLANT, V9, P737, DOI 10.1053/jlts.2003.50122-
dc.description.citedreferenceLo CM, 2003, LIVER TRANSPLANT, V9, P626, DOI 10.1053/jlts.2003.50081-
dc.description.citedreferenceOnaca NN, 2003, AM J TRANSPLANT, V3, P626-
dc.description.citedreferenceSaab S, 2003, LIVER TRANSPLANT, V9, P473, DOI 10.1053/jlts.2003.50090-
dc.description.citedreferenceOnaca NN, 2003, LIVER TRANSPLANT, V9, P117, DOI 10.1053/jlts.2003.50027-
dc.description.citedreferenceSUGAWARS Y, 2003, TRANSPLANTATION, V73, pS20-
dc.description.citedreferenceSuh KS, 2002, LIVER TRANSPLANT, V8, P910, DOI 10.1053/jlts.2002.35665-
dc.description.citedreferenceGhobrial RM, 2002, LIVER TRANSPLANT, V8, P901, DOI 10.1053/jlts.2002.35548-
dc.description.citedreferenceBrown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340-
dc.description.citedreferenceYao FY, 2001, HEPATOLOGY, V33, P1394-
dc.description.citedreferenceKamath PS, 2001, HEPATOLOGY, V33, P464-
dc.description.citedreferenceWEISNER RH, 2001, LIVER TRANSPLANT, V7, P567-
dc.description.citedreferenceMalinchoc M, 2000, HEPATOLOGY, V31, P864-
dc.description.citedreferenceKiuchi T, 1999, TRANSPLANTATION, V67, P321-
dc.description.citedreferenceCLAVIEN PA, 1994, ANN SURG, V220, P109-
dc.description.tc16-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share